Haypp Group AB reported robust growth in its Q4 2024 earnings, driven by a 16% increase in nicotine pouch volume and significant advancements in both core and growth markets. The company's stock ...
The U.S. Food and Drug Administration (FDA) has authorized the marketing of Zyn nicotine pouches as a reduced-risk ...
Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...
New York lawmakers are pushing to ban flavored nicotine pouches like Zyn, citing concerns they appeal to minors.
Zyns are in, cigarettes are back, everyone’s on amphetamines and drinking alcohol is done. The Post spoke with nearly a dozen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results